Personas / Equipo Humano

Clàudia Fortuny Guasch

Buscador de publicaciones

Publicaciones

  • Noguera-Julián A, Gamell Fullà A, Ruggiu GM, Cusó T, Latre C, Manuel Monsonis Cabedo and Fortuny-Guasch C.

    Shorter Treatment for Nonsevere Pediatric Tuberculosis: A Single-center Case Series in a Low-burden Country.

    ARCHIVOS DE BRONCONEUMOLOGIA . 30(12): 776-778.

    [doi:10.1016/j.arbres.2024.07.009]

  • Pons-Tomàs G, Irene Martínez de Albéniz, Rios-Barnés M, Gamell Fullà A, Simó-Nebot S, Balsells S, Hernández-García M, Melé-Casas M, Sánchez E, Manuel Monsonis Cabedo, Gene-Giralt A, López M, Salvia D, García-García JJ, Fortuny-Guasch C and Fumadó V.

    Serological Outcome in the First Months of Life of Children Born to Mothers with SARS-CoV-2 Infection during Pregnancy

    CHILDREN-BASEL . 11(9): .

    [doi:10.3390/children11091095]

  • Pons-Tomas, Gemma, Hernandez-Garcia, Maria, Mele-Casas, Maria, Fernández de Sevilla-Estrach M, Launes-Montana C, Girona M, Rios-Barnés M, Bassat Q, Ajanovic, Sara, Cubells M, Claverol J, Penela-Sanchez, Daniel, Jou-Munoz C, Manuel Monsonis Cabedo, Esteva-Afonso C, Fassanella, Assumpta, Cuadras-Palleja D, Munoz-Almagro C, Jordán-García I, Fortuny-Guasch C, García-García JJ and Fumadó V.

    Clinical Characterization, Transmissibility, and Seroconversion of SARS-CoV-2 Infection in Children (before the Start of Vaccination) in the Barcelona Metropolitan Region (Spain)

    Journal of Pediatric Infectious Diseases . 19(05): 251-259.

    [doi:10.1055/s-0044-1787676]

  • Pons-Tomàs G, Pino-Ramirez RM, Soler-García a, Launes-Montana C, Irene Martínez de Albéniz, Rios-Barnés M, Melé-Casas M, Hernández-García M, Manuel Monsonis Cabedo, Gene-Giralt A, Fernández de Sevilla-Estrach M, García-García JJ, Fortuny-Guasch C and Fumadó V.

    Deciphering the Longevity and Levels of SARS-CoV-2 Antibodies in Children: A Year-Long Study Highlighting Clinical Phenotypes and Age-Related Variations

    PATHOGENS . 13(8): .

    [doi:10.3390/pathogens13080622]

  • Gamell Fullà A, Velasco E, López-Ramos MG, Rios-Barnés M, Simó-Nebot S, Fumadó V, Noguera-Julián A and Fortuny-Guasch C.

    Off-label use of dalbavancin in children: a case series

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 79(8): 2062-2067.

    [doi:10.1093/jac/dkae212]

  • Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny-Guasch C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C and Ford D.

    D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years

    Contemporary Clinical Trials . 142: 107540-107540. Nº de citas: 3

    [doi:10.1016/j.cct.2024.107540]

  • Agüera M, Soler-García a, Alejandre C, Moussalam-Merino S, Sala-Castellví P, Pons G, Penela-Sánchez D, González-Grado C, Alsina-Rosell J, Climent C, Esteva-Afonso C, Fortuny-Guasch C, Fernández de Sevilla-Estrach M, García-García JJ, Brotons-de los Reyes P, Balaguer A, Estrada J, Jordán-García I, Munoz-Almagro C and Launes-Montana C.

    Nirsevimab immunization's real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study

    PEDIATRIC ALLERGY AND IMMUNOLOGY . 35(6): . Nº de citas: 2

    [doi:10.1111/pai.14175]

  • Alarcon A, de Vries LS, Parodi A, Arnáez J, Cabañas F, Steggerda SJ, Rebollo M, Ramenghi L, Dorronsoro I, López-Azorín M, Schneider J, Noguera-Julián A, Rios-Barnés M, Recio M, Bickle-Graz M, Martínez-Biarge M, Fortuny-Guasch C, García-Alix A and Truttmann AC.

    Neuroimaging in infants with congenital cytomegalovirus infection and its correlation with outcome: emphasis on white matter abnormalities

    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION . 109(2): 151-158. Nº de citas: 11

    [doi:10.1136/archdischild-2023-325790]

  • Epalza, C, Valadés-Alcaraz, A, González-Alba, JM, Beltrán-Pavez, C, Gutiérrez-López, M, Rubio-Garrido, M, Fortuny-Guasch C, Frick, MA, Medina, LM, Moreno, S, Sanz, J, Rojo, P, Navarro, ML and Holguín, A.

    Transmitted Drug Resistance and HIV Diversity Among Adolescents Newly Diagnosed With HIV in Spain

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 43(1): 40-48. Nº de citas: 1

    [doi:10.1097/INF.0000000000004138]

  • Blanco Y, Escudero D, Lleixà C, Llufriu S, Egri N, García RR, Alba M, Aguilar E, Artola M, Aldea Novo M, Alvarez S, Caballero E, Cabrera-Maqueda JM, Fonseca E, Guasp M, Hernando A, Martinez-Hernandez E, Olivé-Cirera G, Lopez-Contreras J, Martín-Aguilar L, Martinez-Martinez L, Rombauts A, Rodés M, Sabater L, Sepulveda M, Solana E, Tejada-Illa C, Vidal-Fernández N, Vilella A, Fortuny-Guasch C, Armangue-Salvador T, Dalmau JO, Querol L and Saiz A.

    mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 10(6): . Nº de citas: 3

    [doi:10.1212/NXI.0000000000200163]